6-Phospho-D-glucono-1,5-lactone

CAS: 2641-81-8

Ref. 3D-MP146204

Información del producto

• Nombre: 6-Phospho-D-glucono-1,5-lactone
• Sinónimos: 6-Phosphoglucono-delta-lactone, (3,4,5-Trihydroxy-6-oxotetrahydro-2H-pyran-2-yl)methyl dihydrogen phosphate, (3,4,5-Trihydroxy-6-oxotetrahydro-2H-pyran-2-yl)methyldihydrogen-phosphat, 6-Phospho-<span class="text-smallcaps">D</span>-glucono-1,5-lactone, 6-Phosphoglucono-δ-lactone, <span class="text-smallcaps">D</span>-Gluconic acid, δ-lactone, 6-(dihydrogen phosphate), Dihydrogène phosphate de (3,4,5-trihydroxy-6-oxotétrahydro-2H-pyran-2-yl)méthyle, Gluconic acid, δ-lactone, 6-(dihydrogen phosphate), <span class="text-smallcaps">D</span>-, δ-6-Phosphogluconolactone, δ-Gluconolactone 6-phosphate, (3,4,5-Trihydroxy-6-oxotetrahydro-2H-pyran-2-yl)methyl dihydrogen phosphate (non-preferred name), D-Gluconic acid, δ-lactone, 6-(dihydrogen phosphate), Gluconic acid, δ-lactone, 6-(dihydrogen phosphate), D-

Descripción

6-Phospho-D-glucono-1,5-lactone is a metabolite of D-gluconic acid that is formed by the action of a phosphoglucoisomerase. 6PGL has been shown to inhibit the growth of colorectal adenocarcinoma cells and to be effective against infectious diseases such as malaria. It is also involved in energy metabolism and cell division in plants. 6PGL may also have anticancer effects, as it inhibits prostate cancer cells and induces apoptosis through activation of epidermal growth factor receptor (EGFR) and inhibition of EGFR tyrosine kinase activity. It has been shown to act on redox potential, enzyme activities, and oxidative injury in liver cells.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 258.12 g/mol
• Fórmula: C₆H₁₁O₉P
• Pureza: Min. 95%